2007 to 2019 Saw Increase in Inflation-Adjusted Health Care Spending
WEDNESDAY, May 29, 2024 (HealthDay News) — From 2007 to 2019, there was an increase in...
Read More
Old-Allergy
Rates of Severe Multiple Drug Intolerance Syndrome Up in Fibromyalgia, IBS
THURSDAY, May 23, 2024 (HealthDay News) — Patients with fibromyalgia and irritable bowel...
Read More
Few Adults With Moderate, Severe Asthma Receive Recommended Inhaler Regimen
THURSDAY, May 23, 2024 (HealthDay News) — Only 14.5 percent of adult patients with moderate...
Read More
Watchdog Group Says U.S. Food Recalls Rose Again Last Year
THURSDAY, April 25, 2024 (HealthDay News) — U.S. recalls of foods for salmonella, foreign...
Read More
FDA Adds Fasenra Indication for Severe Asthma in Children
TUESDAY, April 16, 2024 (HealthDay News) — The U.S. Food and Drug Administration has...
Read More
Penicillin Allergy Can Be Delabeled by Nonallergy Providers
TUESDAY, April 9, 2024 (HealthDay News) — Direct oral penicillin challenges (DPCs) can be...
Read More
Bypassing Oral Immunotherapy Buildup Safe in Children With Food Allergy
THURSDAY, March 21, 2024 (HealthDay News) — An initial phase of multifood sublingual...
Read More
Clinical Signs Tied to Rhinosinusitis ID’d in Patients With Nasal Allergies
MONDAY, March 11, 2024 (HealthDay News) — Clinical signs associated with chronic...
Read More
AAAAI: Early-Life Day Care Attendance May Lower Risk for Asthma, Allergies
WEDNESDAY, March 6, 2024 (HealthDay News) — Early-life day care attendance may be protective...
Read More
AAAAI: Nasal Delivery of Epinephrine Safe, Effective for Anaphylaxis
WEDNESDAY, March 6, 2024 (HealthDay News) — Nasal powder formulations of epinephrine are...
Read More
Fine Particulate Matter Levels Below WHO Guidelines Tied to Hospital Admission
MONDAY, Feb. 26, 2024 (HealthDay News) — Chronic and daily exposure to fine particulate...
Read More
AAAAI: Omalizumab Superior to Placebo for Those With Multiple Food Allergies
MONDAY, Feb. 26, 2024 (HealthDay News) — Omalizumab treatment for 16 weeks is superior to...
Read More
Expanded Use of Xolair to Treat Food Allergies Approved by the FDA
FRIDAY, Feb. 16, 2024 (HealthDay News) — The U.S. Food and Drug Administration has expanded...
Read More
Asthma More Common Among Youth Reporting Cannabis Use
WEDNESDAY, Feb. 7, 2024 (HealthDay News) — Asthma is more common among youth who use...
Read More
FDA Approves Dupilumab for Children With Eosinophilic Esophagitis
MONDAY, Jan. 29, 2024 (HealthDay News) — The U.S. Food and Drug Administration has approved...
Read More
Practitioner Empathy Interventions Can Improve Patient Satisfaction
MONDAY, Jan. 29, 2024 (HealthDay News) — Health care practitioner empathy interventions seem...
Read More
Exhalation Delivery System With Fluticasone Effective for Rhinosinusitis
FRIDAY, Jan. 26, 2024 (HealthDay News) — For patients with chronic rhinosinusitis (CRS), an...
Read More
Climatic Hazards Linked to Aggravation of Atopic Dermatitis
WEDNESDAY, Jan. 24, 2024 (HealthDay News) — Climatic hazards are likely to aggravate atopic...
Read More
CDC: 5.7 Percent of Adults Lacked Reliable Transportation in 2022
THURSDAY, Jan. 11, 2024 (HealthDay News) — In 2022, 5.7 percent of adults reported lacking...
Read More
Drug-Drug Interactions Seen in 21.4 Percent of Children With Meds Exposure
THURSDAY, Jan. 4, 2024 (HealthDay News) — More than 20 percent of children with two or more...
Read More